Unlimited Bio Blog
Welcome to the Unlimited Bio Blog. Home for long-form posts on longevity gene therapies, anti-aging science, and the real-world logic behind experimental longevity medicine. You’ll find protocol-style writeups on topics like VEGF gene therapy (e.g., hair loss and scalp microvascular biology), follistatin (FST) pathways, and other regenerative targets discussed in the context of clinical trials, translational research, and combination approaches to extend lifespan and healthspan. We focus on clear reasoning, measurement, and uncertainty: study design, endpoints, bias control, and what “evidence” should mean when biology is noisy. This blog is informational. Some posts describe N-of-1 self-experiments and personal case studies. Nothing here is medical advice, and we do not provide instructions for performing medical interventions.
Stay tuned for the latest Unlimited Bio posts on longevity gene therapy, including deep dives into emerging targets (such as VEGF and follistatin) and how they relate to anti-aging research, lifespan and healthspan, and ongoing accumulation of evidence. We publish updates that connect mechanisms to outcomes—covering topics like angiogenesis, tissue microenvironments, biomarkers, imaging, and repeatable measurement—alongside commentary on clinical trial progress, partnerships, and scientific milestones shaping next-generation therapies.